Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 59

Results For "TN"

3628 News Found

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept


Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing
People | June 02, 2026

Imaging Endpoints appoints Srikanth Ayyappan as AVP, Global Marketing

Based in the global marketing function, he will be responsible for strengthening the company's visibility among sponsors, partners and industry stakeholders worldwide


CORONA Remedies receives EU-GMP certification for hormone facility
News | June 02, 2026

CORONA Remedies receives EU-GMP certification for hormone facility

Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets


Marksans Pharma to acquire Netherlands-based QliniQ
News | June 02, 2026

Marksans Pharma to acquire Netherlands-based QliniQ

Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets


CellCarta and Leica Biosystems expand push to streamline precision medicine development
News | June 02, 2026

CellCarta and Leica Biosystems expand push to streamline precision medicine development

The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments


Ebola vax on the anvil?
News | June 02, 2026

Ebola vax on the anvil?

CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate


Aragen scales Renaissance Pharma’s cancer antibody to commercial GMP in just 9 months
Biopharma | June 02, 2026

Aragen scales Renaissance Pharma’s cancer antibody to commercial GMP in just 9 months

Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru


AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery
Hospitals | June 02, 2026

AIIMS Delhi and Raipur use Intuitive’s tech to conduct tele-mentored robotic surgery

Real-time remote collaboration during robotic-assisted cholecystectomy showcases new possibilities for surgical mentoring, education, and knowledge sharing across institutions


Takeda promotes Garima Srivastava as VP HR, Global Head of Talent Acquisition for Commercial
People | June 01, 2026

Takeda promotes Garima Srivastava as VP HR, Global Head of Talent Acquisition for Commercial

Seasoned HR leader brings over 15 years of experience in global talent strategy, organizational transformation, and workforce planning


Pfizer and Innovent Biologics strike $10 billion cancer drug deal
News | June 01, 2026

Pfizer and Innovent Biologics strike $10 billion cancer drug deal

This alliance, covering up to 12 antibody drugs, highlights the growing trend of large-scale collaborations between Chinese biotech firms and global pharmaceutical giants